Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited 0874.HK Stock
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Price Chart
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited 0874.HK Financial and Trading Overview
Contents
- Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Price Chart
- Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited 0874.HK Financial and Trading Overview
- Valuation Measures
- Trading Information
- Financial Highlights
- Profile of Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
- Q&A For Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Stock
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited stock price | 19.76 HKD |
Previous Close | 24.2 HKD |
Open | 24.2 HKD |
Bid | 24.05 HKD x 0 |
Ask | 24.25 HKD x 0 |
Day's Range | 24 - 24.35 HKD |
52 Week Range | 16.56 - 27.7 HKD |
Volume | 1.02M HKD |
Avg. Volume | 1.08M HKD |
Market Cap | 56.07B HKD |
Beta (5Y Monthly) | 0.744827 |
PE Ratio (TTM) | 8.745454 |
EPS (TTM) | 2.7 HKD |
Forward Dividend & Yield | 0.81 (3.35%) |
Ex-Dividend Date | June 14, 2023 |
1y Target Est | 26 HKD |
0874.HK Valuation Measures
Enterprise Value | 33.7B HKD |
Trailing P/E | 8.745454 |
Forward P/E | 8.293103 |
PEG Ratio (5 yr expected) | 1.57 |
Price/Sales (ttm) | 0.7801292 |
Price/Book (mrq) | 1.1511033 |
Enterprise Value/Revenue | 0.469 |
Enterprise Value/EBITDA | 7.354 |
Trading Information
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Stock Price History
Beta (5Y Monthly) | 0.744827 |
52-Week Change | 9.25% |
S&P500 52-Week Change | 20.43% |
52 Week High | 27.7 HKD |
52 Week Low | 16.56 HKD |
50-Day Moving Average | 25.49 HKD |
200-Day Moving Average | 22.27 HKD |
0874.HK Share Statistics
Avg. Volume (3 month) | 1.08M HKD |
Avg. Daily Volume (10-Days) | 742.91K HKD |
Shares Outstanding | 219.9M |
Float | 850.76M |
Short Ratio | N/A |
% Held by Insiders | 0% |
% Held by Institutions | 31.12% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0.732 |
Trailing Annual Dividend Yield | 3.02% |
5 Year Average Dividend Yield | 268.00% |
Payout Ratio | 0.2747 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | March 31, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | 5.66% |
Operating Margin (ttm) | 5.70% |
Gross Margin | 18.69% |
EBITDA Margin | 6.37% |
Management Effectiveness
Return on Assets (ttm) | 3.64% |
Return on Equity (ttm) | 12.58% |
Income Statement
Revenue (ttm) | 71.88B HKD |
Revenue Per Share (ttm) | 44.21 HKD |
Quarterly Revenue Growth (yoy) | 5.29% |
Gross Profit (ttm) | 13.24B HKD |
EBITDA | 4.58B HKD |
Net Income Avi to Common (ttm) | 4.07B HKD |
Diluted EPS (ttm) | 2.75 |
Quarterly Earnings Growth (yoy) | 5.70% |
Balance Sheet
Total Cash (mrq) | 20.3B HKD |
Total Cash Per Share (mrq) | 12.49 HKD |
Total Debt (mrq) | 13.02B HKD |
Total Debt/Equity (mrq) | 36.58 HKD |
Current Ratio (mrq) | 1.686 |
Book Value Per Share (mrq) | 20.893 |
Cash Flow Statement
Operating Cash Flow (ttm) | 3.24B HKD |
Levered Free Cash Flow (ttm) | -1321152128 HKD |
Profile of Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
Country | Hong Kong |
State | N/A |
City | Guangzhou |
Address | No. 45, Shamian North Street |
ZIP | 510130 |
Phone | 86 20 6628 1011 |
Website | https://www.gybys.com.cn |
Industry | Drug Manufacturers-Specialty & Generic |
Sector(s) | Healthcare |
Full Time Employees | 24249 |
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited, together with its subsidiaries, engages in the research, development, manufacture, and sale of Chinese patent and Western medicines, chemical raw materials, natural and biological medicines, and intermediates of chemical raw materials in the People's Republic of China and internationally. The company operates through four segments: Great Southern Medicine, Great Commerce, Great Health, and Great Medical Care. It is also involved in the wholesale, retail, sale, import, and export of Western and Chinese medicines, and medical devices; and research and development, production, and sale of beverages, food, healthcare products, and other products; and production and sale of pre-packaged food, dairy products, etc., as well as offers herbal tea, tablets, capsules, lozenges, Guiling jellies, etc. In addition, the company invests in health industry, such as medical services, health management, health care, elderly care, etc.; and provides business and advertising agency services. It operates retail chain pharmacy stores and retail stores. The company was formerly known as Guangzhou Pharmaceutical Company Limited and changed its name to Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited in August 2013. Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited was incorporated in 1997 and is based in Guangzhou, China.
Q&A For Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Stock
What is a current 0874.HK stock price?
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited 0874.HK stock price today per share is 19.76 HKD.
How to purchase Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited stock?
You can buy 0874.HK shares on the HKSE exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited?
The stock symbol or ticker of Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited is 0874.HK.
Which industry does the Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited company belong to?
The Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited industry is Drug Manufacturers-Specialty & Generic.
How many shares does Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited have in circulation?
The max supply of Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited shares is 2.47B.
What is Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited Price to Earnings Ratio (PE Ratio)?
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited PE Ratio is 7.31851860 now.
What was Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited earnings per share over the trailing 12 months (TTM)?
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited EPS is 2.7 HKD over the trailing 12 months.
Which sector does the Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited company belong to?
The Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited sector is Healthcare.
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited 0874.HK included in indexes
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
---|
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
---|---|---|---|---|---|---|---|
{{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
Nasdaq EM Plus Korea Small Cap NQEMKRSCGBP | 1476.35 GBP 1888.16 USD |
<0.01
|
— — | 1476.35 GBP 1888.16 USD | 1476.35 GBP 1888.16 USD | — - | — — |
- {{ link.label }} {{link}}